Relapsed/Refractory Aggressive B-cell Lymphomas
Also known as: Relapsed/Refractory Aggressive B-Cell Lymphoma
Drug | Drug Name | Drug Description |
---|
Drug | Drug Name | Target | Type |
---|
Drug | Drug Name | Phase | Status | Count |
---|---|---|---|---|
DB14707 | Cemiplimab | 1 | Recruiting | 1 |
DB16684 | Odronextamab | 1 | Recruiting | 1 |
DB12530 | Inebilizumab | 1 / 2 | Completed | 1 |
DB15768 | MEDI0680 | 1 / 2 | Completed | 1 |